Literature DB >> 23926944

A family cluster of giardiasis with variable treatment responses: refractory giardiasis in a family after a trip to India.

A Requena-Méndez1, P Goñi, S Lóbez, I Oliveira, E Aldasoro, M-E Valls, A Clavel, J Gascón, J Muñoz.   

Abstract

Persistence of giardiasis after some of the recommended drugs is occurring with increasing frequency. We describe the follow-up of four members of a family with giardiasis through microscopic observation, immunochromatography and PCRs of tpi and β-giardin genes. Three patients did not respond to tinidazole but they were cured after quinacrine. However, PCR became negative at 2 months after negativization of stools in two patients and after 1 year in one patient. In all cases Giardia assemblage B was characterized with high homology between all isolates. Further studies are needed to determine the value of PCR in the diagnosis of Giardia infections.
© 2013 The Authors Clinical Microbiology and Infection © 2013 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Giardia; nitroimidazole; polymerase chain reaction; quinacrine; refractory giardiasis

Mesh:

Substances:

Year:  2013        PMID: 23926944     DOI: 10.1111/1469-0691.12327

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  8 in total

Review 1.  Understanding drug resistance in human intestinal protozoa.

Authors:  Hend Aly El-Taweel
Journal:  Parasitol Res       Date:  2015-03-19       Impact factor: 2.289

2.  Treatment of giardiasis: current status and future directions.

Authors:  Richard R Watkins; Lars Eckmann
Journal:  Curr Infect Dis Rep       Date:  2014-02       Impact factor: 3.725

3.  Treatment of giardiasis after nonresponse to nitroimidazole.

Authors:  Eyal Meltzer; Tamar Lachish; Eli Schwartz
Journal:  Emerg Infect Dis       Date:  2014-10       Impact factor: 6.883

Review 4.  Cryptosporidium and Giardia in Africa: current and future challenges.

Authors:  Sylvia Afriyie Squire; Una Ryan
Journal:  Parasit Vectors       Date:  2017-04-20       Impact factor: 3.876

5.  Genetic variation in metronidazole metabolism and oxidative stress pathways in clinical Giardia lamblia assemblage A and B isolates.

Authors:  Christina S Saghaug; Christian Klotz; Juha P Kallio; Hans-Richard Brattbakk; Tomasz Stokowy; Toni Aebischer; Inari Kursula; Nina Langeland; Kurt Hanevik
Journal:  Infect Drug Resist       Date:  2019-05-10       Impact factor: 4.003

6.  Characterization of Metronidazole-Resistant Giardia intestinalis Lines by Comparative Transcriptomics and Proteomics.

Authors:  Sascha Krakovka; Ulf Ribacke; Yukiko Miyamoto; Lars Eckmann; Staffan Svärd
Journal:  Front Microbiol       Date:  2022-02-10       Impact factor: 6.064

Review 7.  Drug Development Against the Major Diarrhea-Causing Parasites of the Small Intestine, Cryptosporidium and Giardia.

Authors:  Yukiko Miyamoto; Lars Eckmann
Journal:  Front Microbiol       Date:  2015-11-19       Impact factor: 5.640

8.  Molecular Genotyping of Giardia duodenalis Isolates from Symptomatic Individuals Attending Two Major Public Hospitals in Madrid, Spain.

Authors:  Aida de Lucio; Rocío Martínez-Ruiz; Francisco J Merino; Begoña Bailo; María Aguilera; Isabel Fuentes; David Carmena
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.